Complex aphthosis and Behçet's disease

Dermatologic Clinics

Volumn 21, Issue 1, 2003, Pages 41-48

  McCarty, Martha Ann ^a   Garton, Rachel A ^a   Jorizzo, Joseph L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANESTHETIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APHTHOUS STOMATITIS; ARTHRITIS; BEHCET DISEASE; CLINICAL FEATURE; EYE DISEASE; GASTROINTESTINAL DISEASE; GENITAL ULCER; HUMAN; MOUTH ULCER; NEUROLOGIC DISEASE; NEUTROPENIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; TERATOGENICITY;

BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MALE; RECURRENCE; STOMATITIS, APHTHOUS; ULCER;

EID: 0037284462     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00058-X     Document Type: Review

References (56)

1. Jorizzo JL, Taylor RS, Schmalstieg FC, et al. Complex aphthosis: a forme fruste of Behçet's syndrome? J Am Acad Dermatol 1985;13:80-4.
2. Schreiner DT, Jorizzo JL. Behçet's disease and complex aphthosis. Dermatol Clin 1987;5:769-78.
3. Embil JA, Stephens RG, Manuel FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975;113:627-30.
4. Rees TD, Binnie WH. Recurrent aphthous stomatitis. Dermatol Clin 1996;14:243-56.
5. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dental Assoc 1996;127:1202-13.
6. Ghate J, Jorizzo JL. Behçet's disease and complex aphthosis. J Am Acad Dermatol 1999;40:1-18.
7. Zouboulis C. Epidemiology of adamantiades-Behçet's disease. In: Bang D, Lee ES, Lee S, editors. Behçet's disease: proceedings of the 8th and 9th International Conference on Behçet's disease. Seoul: Design Mecca; 2000. p. 43-7.
8. Stewart JAB. Genetic analysis of families with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 1986;45:265-8.
9. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997;38:423-35.
10. Kone-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr 1998;132:721-5.
11. Rogers RS. Recurrent aphthous stomatitis in the diagnosis of Behçet's disease. Yonsei Med J 1997;38:370-9.
12. Ferraz MB, Walter SD, Heymann R, et al. Sensitivity and specificity of different diagnostic criteria for Behçet's disease according to the latent class approach. Br J Rheumatol 1995;34:932-5.
13. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-178.
14. Wechsler B, Davatchi F, Mizushima Y. Evaluation of diagnostic ("classification") criteria in Behçet's disease: toward internationally agreed criteria. In: O'Duffy JD, Kokmen E, editors. Behçet's Disease: Basic and Clinical Aspects. New York: Marcel Dekker, Inc.; 1991. p. 11-39.
15. O'Duffy JD, Goldstein NP. Neurologic involvement in seven patients with Behçet's disease. Am J Med 1976;61:170-8.
16. Chams-Davatchi C, Davatchi F, Shahram F, et al. Classification of muco-cutaneous lesions of Behçet's disease. In: Bang D, Lee ES, Lee S, editors. Behçet's disease: proceedings of the 8th and 9th international conference on Behçet's disease. Seoul: Design Mecca; 2000. p. 283-5.
17. Hutton KP, Rogers RS. Recurrent aphthous stomatitis. Dermatol Clin 1987;5:761-8.
18. Jorizzo JL, Hudson RD, Schmalstieg FC, et al. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration and colchicine therapy. J Am Acad Dermatol 1984;10:205-14.
19. McNeely MC, Jorizzo JL, Solomon AR, et al. Primary idiopathic cutaneous pustular vasculitis. J Am Acad Dermatol 1986;14:939-44.
20. El Ramahi KM, Al Dalaan A, Al Shaikh A, et al. Renal involvement in Behçet's disease: review of 9 cases. J Rheumatol 1998;25:2254-9.
21. Jorizzo JL. Behçet's disease. In: Freedberg IM, Eisen AZ, Wolff AZ, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 1999. p. 2161-5.
22. Saylan T, Mat C, Fesko I, et al. Behçet's disease in the Middle East. Clin Dermatol 1999;17:209-23.
23. Dundar SV, Gencalp U, Simsek H. Familial cases of Behçet's disease. Br J Dermatol 1985;113:319-21.
24. Niwa Y, Mizushima Y. Neutrophil-potentiating factors released from stimulated lymphocytes: special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease. Clin Exp Immunol 1990;79:353-60.
25. Hegab S, Al-Mutawa S. Immunopathogenesis of Behçet's disease. Clin Immunol 2000;96:174-86.
26. Lee S, Bang D, Cho YH, et al. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res 1996;288:179-83.
27. Lehner T. The role of a disorder in immunoregulation associated with herpes simplex virus type I in Behçet's disease. In: Lehner T, Barnes CG, editors. Recent advances in Behçet's disease. London: Royal Society of Medicine Services; 1986. p. 31.
28. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med 1999;341:1284-91.
29. Jorizzo JL, Solomon AR, Cavallo T. Behçet's syndrome: immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow up. Arch Pathol Lab Med 1985;109:747-51.
30. Jorizzo JL, Schmalstieg FC, Solomon AR, et al. Thalidomide effects in Behçet's syndrome and pustular vasculitis. Arch Intern Med 1986;146:878-81.
31. Sahin S, Akoglu T, Direskeneli H, et al. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996;55:128-33.
32. Rogers RS. Mucocutaneous manifestations of Behçet's disease. In: Bang D, Lees ES, Lee E, editors. Behçet's disease: proceedings of the 8th and 9th international conference on Behçet's disease. Seoul: Design Mecca; 2000. p. 265-8.
33. Balabanova M, Calamia KT, Perniciaro C, et al. A study of the cutaneous manifestations of Behçet's disease in patients from the United States. J Am Acad Dermatol 1999;41:540-5.
34. Jorizzo JL, Solomon AR, Zanolli MD, et al. Neutrophilic vascular reactions. J Am Acad Dermatol 1988;19:983-1005.
35. Bhisitkul RB, Foster CS. Diagnosis and ophthalmological features of Behçet's disease. Int Ophthalmol Clin 1996;36:127-34.
36. Kidd D, Steuer A, Denman AM, et al. Neurological complications in Behçet's syndrome. Brain 1999;122:2183-94.
37. Siva A, Kantarci OH, Saip S, et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.
38. Sagdic K, Ozer ZG, Saba D, et al. Venous lesions in Behçet's disease. Eur J Vasc Endovasc Surg 1996;11:437-40.
39. James DG, Thomson A. Recognition of the diverse cardiovascular manifestations of Behçet's disease. Am Heart J 1982;103:457-8.
40. Jorizzo JL, Abernethy JL, White WL, et al. Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995;32:968-76.
41. Lakhanpal S, Tani K, Lie JT, et al. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-5.
42. Bang D, Hur W, Lee ES, et al. Prognosis and clinical relevance of recurrent oral ulceration in Behçet's disease. J Dermatol 1995;22:926-9.
43. Abdollahi A, Hallaji Z, Jamshidi A, et al. Visual outcome of the early and late treatment in ocular Behçet's disease. In: Bang D, Lee ES, Lee E, editors. Behçet's disease: proceedings of the 8th and 9th international conference on Behçet's disease. Seoul: Design Mecca; 2000. p. 394-8.
44. Sakamoto M, Akazawa K, Nishioka Y, et al. Prognostic factors of vision in patients with Behçet's disease. Ophthalmology 1995;102:317-21.
45. Miyachi Y, Taniguchi S, Ozaki M, et al. Colchicine in the treatment of cutaneous manifestations of Behçet's disease. Br J Dermatol 1981;104:67-9.
46. Sharquie KE. Suppression of Behçet's disease with dapsone. Br J Dermatol 1984;110:493-4.
47. Yasui K, Ohta K, Kobayashi M, et al. Successful treatment of Behçet's disease with pentoxifylline. Ann Intern Med 1996;124:891-3.
48. Hamuryudan V, Mat C, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome: a randomized double-blinded, placebo controlled trial. Ann Intern Med 1998;128:443-50.
49. Kaklamani V, Kaklamanis P. Treatment of Behçet's disease: an update. Semin Arthritis Rheum 2001;30:299-312.
50. O'Duffy JD, Calamia K, Cohen S, et al. Interferon-alpha treatment of Behçet's disease. J Rheumatol 1998;25:1938-44.
51. Goossens PH, Verburg RJ, Breedveld FC. Remission of Behqet's syndrome with tumour necrosis factor α blocking therapy. Ann Rheum Dis 2001;60:637.
52. Nussenblatt RB, Palestine AG, Chan CC, et al. Effectiveness of cyclosporine therapy for Behçet's disease. Arthritis Rheum 1985;28:671-9.
53. O'Duffy JD, Robertson DM, Goldstein NP. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease. Am J Med 1984;76:75-84.
54. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5.
55. Hassard PV, Binder SW, Nelson V, et al. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report. Gastroenterology 2001;120:995-9.
56. Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab in sight threatening panuveitis in Behçet's disease. Lancet 2001;358:295-6.